Company Details

Dotbiohk Limited

DotBioHK Limited (“DotBioHK”) is a Hong Kong-based, wholly-owned subsidiary of DotBio Pte Ltd (DotBio), a Singapore-based biopharmaceutical start-up focusing on next-generation multi-specific antibody drugs. DotBio has a proprietary humanized, stable Domain Therapeutic Antibody (“Dotbody”) technology that will revolutionize multi-specific therapies, antibody-drug conjugates and CAR-T therapies. DotBio currently possess proprietary state-of-art DotBody and Fab phage display libraries, as well as numerous pre-clinical assets in the immune-oncology field. Meanwhile, DotBioHK will has a major focus on non-oncology therapeutic areas.

The information provided on this page is for reference only. Please refer to the latest information published by the partner company.

Contact Us

For general enquiry, or questions about HKSTP’s services and support, please enter your email address and query here.